MyoKardia (MYOK) Tops Q4 EPS by 20c

March 8, 2018 4:05 PM

MyoKardia (NASDAQ: MYOK) reported Q4 EPS of ($0.21), $0.20 better than the analyst estimate of ($0.41). Collaboration & License revenue for the quarter came in at $5.6 million versus the consensus estimate of $6.08 million.

For earnings history and earnings-related data on MyoKardia (MYOK) click here.


Earnings Guidance